Desenlaces clínicos en pacientes tratadas por cáncer de mama subtipo triple negativo, Hospital Mayor Mederi 2014-2018

  • Vega-Hernandez, Paula (PI)
  • De LaPeña, Jairo ( Academic assessor)
  • Pedraza, Ana María ( Academic assessor)

Project Details


Triple negative breast cancer is defined as a tumor subtype characterized by the lack of expression of hormone receptors for estrogen and progesterone, and human epidermal growth factor receptor 2 (HER2)are considered to be biologically aggressive with higher rates of distant and visceral metastasis.
Objective: to describe the outcomes of patients with triple-negative breast cancer according to treatment and stage at the time of diagnosis in the population attended Mederi Hospital
Effective start/end date22/08/1922/12/20

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 4 - Quality Education


  • Triple negative breast cancer
  • clinical outcomes
  • Neoadjuvant


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.